Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GS-5885, GS-9451, Tegobuvir and Ribavirin in HCV Genotype 1
NCT01434498Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Sep 2011
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of ledipasvir, vedroprevir, tegobuvir in hepatitis C (HCV), sponsored by Gilead Sciences. Started Sep 2011; status: completed.
02
Drugs
ledipasvirvedroprevirtegobuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01434498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01434498.